Home
Search

Letters, Testimony & Comments

BIO submits letters, testimony, and comments to government and regulatory bodies throughout the United States and around the world.

Featured Letters, Testimony, & Comments
BIO Letter to HRSA on 340B Rebate Model
Under the 340B program, participating manufacturers must offer 340B pricing on their covered outpatient drugs by covered entities, as a condition of having those drugs federally payable under Medicare Part B and Medicaid. Critically, Congress…
Learn more
CSBA Letter to Congressional Leadership on…
Learn more
BIO Comments to the USPTO’s MAY 10, 2024 Proposed…
BIO submitted these comments in response to the United States Patent and Trademark Office’s May 10, 2024, Notice of Proposed Rulemaking regarding Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting.
Learn more
All Letters, Testimony & Comments
  • Show All
Search
Results
Small Business Early Stage Investment Program: Legislative Text
March 10, 2016
The Small Business Early Stage Investment Program would provide matching funds for investment companies who invest in small, high tech companies, including biotech firm.
BIO letter in support of H.R. 5418
March 10, 2016
To establish a pilot program for educating district court judges on patent related issues.
Presentation: "Global Health Challenges: How Industry is Addressing Global Health", presented at the University of Virginia in June 2008
March 10, 2016
Global Health Challenges: How Industry is Addressing Global Health
Ted Roumel, Vice President for Research Innovation & Commercialization at the University of Maryland Biotechnology Institute, USA
March 10, 2016
Innovation And The Global Research Enterprise WORLD HEALTH ORGANIZATION GENEVA—NOVEMBER 2007 THEODORE J. ROUMEL VICE PRESIDENT for RESEARCH, INNOVATION AND COMMERCIALIZATION UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE
BIO Testimony to the House Judiciary Committee Concerning the Hearing on Patent Reform
March 10, 2016
Diran Makinde, Network Director, NEPAD Biosciences, West Africa Biosciences Network (WABNet), Senegal
March 10, 2016
Government's role in developing solutions for diseases that disproportionately affect developing countries
Eileen Yen, former Director, Sarawak Biodiversity Centre, Malaysia
March 10, 2016
Mark Rohrbaugh, Director, Office of Technology Transfer, National Institutes of Health (NIH)
March 10, 2016
Mark Rohrbaugh, Director, Office of Technology Transfer, National Institutes of Health (NIH), US Department of Health & Human Services, USA
The Patent Reform Act of 2007 - Coalition Letter
March 10, 2016
More than 430 organizations representing American innovation in a wide range of industries in all 50 states wrote Senate leaders to express continued concern with S. 1145.
Animal Biotechnology: All About Animal Cloning
March 10, 2016
Cloning is the most recent evolution of selective assisted breeding in animal husbandry. Cloning animals is a reliable way of reproducing superior livestock genetics and ensuring herds are maintained at the highest quality possible.